Cite
Absolute Bioavailability and Pharmacokinetic Comparability of Sirukumab Following Subcutaneous Administration by a Prefilled Syringe or an Autoinjector.
MLA
Zhuang, Y., et al. “Absolute Bioavailability and Pharmacokinetic Comparability of Sirukumab Following Subcutaneous Administration by a Prefilled Syringe or an Autoinjector.” Clinical Pharmacology in Drug Development, vol. 6, no. 6, Nov. 2017, pp. 570–76. EBSCOhost, https://doi.org/10.1002/cpdd.328.
APA
Zhuang, Y., de Vries, D. E., Marciniak, S. J., Liu, H., Zhou, H., Davis, H. M., Leon, F., Raible, D., & Xu, Z. (2017). Absolute Bioavailability and Pharmacokinetic Comparability of Sirukumab Following Subcutaneous Administration by a Prefilled Syringe or an Autoinjector. Clinical Pharmacology in Drug Development, 6(6), 570–576. https://doi.org/10.1002/cpdd.328
Chicago
Zhuang, Y., D. E. de Vries, S. J. Marciniak, H. Liu, H. Zhou, H. M. Davis, F. Leon, D. Raible, and Z. Xu. 2017. “Absolute Bioavailability and Pharmacokinetic Comparability of Sirukumab Following Subcutaneous Administration by a Prefilled Syringe or an Autoinjector.” Clinical Pharmacology in Drug Development 6 (6): 570–76. doi:10.1002/cpdd.328.